Blueberries Medical Corp. announced a non-brokered private placement of 54,498,889 common shares at a price of CAD 0.027 per common share for aggregate gross proceeds of CAD 1,471,470 led by returning investor Terraflos Inc. on November 28, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.015 CAD | -25.00% | -25.00% | -25.00% |
04-26 | Blueberries Medical Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Blueberries Medical Corp. announced that it has received CAD 1.987876 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-25.00% | 5.86M | |
+13.25% | 3.07B | |
+18.71% | 1.77B | |
+97.25% | 671M | |
+2.73% | 527M | |
+49.77% | 174M | |
-9.02% | 94.91M | |
+37.50% | 63.28M | |
+31.46% | 57.02M |
- Stock Market
- Equities
- BBM Stock
- News Blueberries Medical Corp.
- Blueberries Medical Corp. announced that it has received CAD 1.47147 million in funding from Terraflos Inc.